Menu

 

Letter

Post-marketing studies

Post-marketing studies can make important contributions to medical knowledge

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e4740 (Published 16 July 2012)
Cite this as: BMJ 2012;345:e4740

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Martin C Michel, clinical pharmacologist1
  1. 1Institut für Pharmakologie, Johannes Gutenberg Universität, 55101 Mainz, Germany
  1. martin.michel{at}boehringer-ingelheim.com

My experience in collaborating with various drug companies in the design, execution, analysis, and publication of post-marketing surveillance (PMS) studies differs greatly from that described in your recent article.1 The general consensus was that PMS studies serve a scientific purpose. Studies typically had predefined scientific questions and were powered to answer them. Some studies had been recommended by the regulatory authorities, such …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Subscribe

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

Latest comments and most commented

THIS WEEK'S POLL

Read related article

See previous polls